SCHEMBL6650709

SCHEMBL6650709

Cc1ccc(Nc2ccc(C(=O)c3ccccc3)cc2)c(N)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 8/20 0.71
MAPK12 P53778 8/20 0.71
MAPK11 Q15759 8/20 0.71
MAPK14 Q16539 8/20 0.71
GAA P10253 7/20 0.68
MAPT P10636 6/20 0.68
KDM4E B2RXH2 5/20 0.68
GFER P55789 3/20 0.68
NPC1 O15118 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
ALDH1A1 P00352 4/20 0.60
HSD17B10 Q99714 3/20 0.60
THRB P10828 2/20 0.60
HPGD P15428 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.56
GLA P06280 1/20 0.56
RCE1 Q9Y256 1/20 0.56
TDP1 Q9NUW8 1/20 0.51
AKR1C3 P42330 1/20 0.48
AKR1C2 P52895 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8438540 0.89 MAPK13 (0.64) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL11798862 0.85 MAPK13 (0.72) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL6656861 0.85 GAA (0.82) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL4286847 0.85 GAA (0.77) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL6653594 0.84 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL6652732 0.83 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL4940364 0.83 GAA (0.61) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL3978775 0.82 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL11791985 0.82 GAA (0.81) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL27480926 0.81 MAPK13 (0.65) MAPK13MAPK12MAPK11MAPK14GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966424-B1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMA AS (DK) 2004-06-23 EP disclosed
US-6313174-B1 FOR THERAPY AND PROPHYLAXIS OF ASTHMA, ALLERGY, RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, GOUT, ATHEROSCLEROSIS, CHRONIC INFLAMMATORY BOWEL DISEASE, PROLIFERATIVE AND INFLAMMATORY SKIN DISORDERS Leo Pharmaceutical Products Ltd.A/S/ (Løvens kemiske Fabrik Produktionsaktieselskab) (DK) 2001-11-06 US disclosed